Monsanto Roundup Lawsuit

Saturday, March 08, 2008

How to market Seroxat for adolescents - 1998

Benbow statement from 2008
GSK has rejected claims it improperly withheld drug-trial data. Dr Alastair Benbow, medical director for GSK Europe, said: "We firmly believe we acted properly and responsibly in first carrying out this clinical-trials programme and then informing the regulatory agencies when we identified a potential increased risk of suicidal thinking and behaviour in patients under 18."


Then why didn't you tell the regulators about this internal memo from 1998 Mr Benbow?




Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

By Bob Fiddaman

ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING

AVAILABLE FOR DOWNLOAD HERE


PAPERBACK COMING SOON
Post a Comment